{"title": "Dos vacunas experimentales contra el \u00e9bola muestran potencial", "author": "Robert Preidt", "url": "https://consumer.healthday.com/infectious-disease-information-21/virus-health-news-697/dos-vacunas-experimentales-contra-el-eacute-bola-muestran-potencial-708423.html", "hostname": "healthday.com", "description": "Ambas produjeron unos niveles altos de anticuerpos contra el letal virus, afirman unos investigadores", "sitename": "Consumer Health News | HealthDay", "date": "2016-02-25", "id": null, "license": null, "body": null, "comments": "", "commentsbody": null, "raw_text": null, "text": "MI\u00c9RCOLES, 24 de febrero de 2016 (HealthDay News) -- Dos vacunas experimentales contra el \u00e9bola se mostraron promisorias en un ensayo cl\u00ednico, informan unos investigadores.\nLas vacunas provocaron una respuesta inmunitaria y fueron bien toleradas por las personas en un ensayo en fase 2 realizado en Liberia, uno de los pa\u00edses de \u00c1frica occidental que fueron muy afectados por el brote de \u00e9bola de 2014.\nEl estudio fue patrocinado por el Instituto Nacional de Alergias y Enfermedades Infecciosas de EE. UU.\nLos investigadores hab\u00edan planificado seguir evaluando las vacunas en un ensayo m\u00e1s amplio en fase 3 con 28,000 personas, pero el plan se abandon\u00f3 porque el declive en los nuevos casos de \u00e9bola hizo que el estudio de mayor tama\u00f1o resultara imposible.\nEl ensayo en fase 2 evalu\u00f3 la vacuna cAd3-EBOZ, que usa un virus del resfriado derivado del chimpanc\u00e9 para administrar material viral gen\u00e9tico del \u00e9bola. El ensayo tambi\u00e9n evalu\u00f3 la vacuna rVSV-ZEBOV, que utiliza el virus de la estomatitis vesicular (relacionado con el virus de la rabia) para portar el material gen\u00e9tico del \u00e9bola.\nEl ensayo incluy\u00f3 a 1,500 personas a partir de los 18 a\u00f1os de edad sin antecedentes reportados de \u00e9bola, y se llev\u00f3 a cabo a principios de 2015. Los participantes, divididos en grupos de 500 personas, recibieron una de las dos vacunas o una inyecci\u00f3n de soluci\u00f3n salina.\nUn mes despu\u00e9s de recibir la vacuna, se detectaron anticuerpos mensurables contra el \u00e9bola en un 87 por ciento de los que recibieron la vacuna cAd3-EBOZ, y en un 94 por ciento de las 500 personas que recibieron la vacuna rVSV-ZEBOV, se\u00f1alaron los investigadores.\nLos hallazgos fueron presentados el martes por el investigador coprincipal, Fatorma Bolay, director del Instituto Liberiano de Investigaci\u00f3n Biom\u00e9dica, en la Conferencia sobre Retrovirus e Infecciones Oportunistas, en Boston.\nM\u00e1s informaci\u00f3n\nLos Centros para el Control y la Prevenci\u00f3n de Enfermedades (CDC) de EE. UU. ofrecen m\u00e1s informaci\u00f3n sobre el\n[\u00e9bola](http://espanol.cdc.gov/enes/vhf/ebola/index.html%0D%0A).\nArt\u00edculo por HealthDay, traducido por\n[HolaDoctor.com](http://holadoctor.com)\n\u00a9 Derechos de autor 2016, HealthDay", "language": null, "image": "https://consumer.healthday.com/media-library/eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJpbWFnZSI6Imh0dHBzOi8vYXNzZXRzLnJibC5tcy8yMzYyNzE0MC9vcmlnaW4uanBnIiwiZXhwaXJlc19hdCI6MTY5NzE1NTE1Nn0.4mXBXjHobyvq2YQG4IZjvC4zBkDbYZ4wWZORV85hugI/image.jpg?width=1200&height=600&coordinates=0%2C85%2C0%2C85", "pagetype": "article", "links": ["/login", "/contact-us/", "/", "https://consumer.healthday.com/tag/research-development", "https://consumer.healthday.com/tag/health-technology", "https://consumer.healthday.com/tag/research-and-development", "https://consumer.healthday.com/tag/infectious-disease", "https://consumer.healthday.com/tag/viruses", "https://consumer.healthday.com/tag/public-health", "https://consumer.healthday.com/tag/vaccines", "https://www.healthday.com/about-us/", "https://www.healthday.com/about-us/", "https://consumer.healthday.com/healthday-sources-2657488513.html", "https://consumer.healthday.com/editorial-and-fact-checking-policy-2657488919.html", "https://consumer.healthday.com/editorial-and-fact-checking-policy-2657488919.html", "http://espanol.cdc.gov/enes/vhf/ebola/index.html%0D%0A", "http://holadoctor.com", "#outdated", "mailto:solutions@healthday.com", "https://consumer.healthday.com/u/robert_preidt", "https://consumer.healthday.com/tag/research-development", "https://consumer.healthday.com/tag/health-technology", "https://consumer.healthday.com/tag/research-and-development", "https://consumer.healthday.com/tag/infectious-disease", "https://consumer.healthday.com/tag/viruses", "https://consumer.healthday.com/tag/public-health", "https://consumer.healthday.com/tag/vaccines", "https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fconsumer.healthday.com%2Finfectious-disease-information-21%2Fvirus-health-news-697%2Fdos-vacunas-experimentales-contra-el-eacute-bola-muestran-potencial-708423.html%3Fxrs%3DRebelMouse_fb%26ts%3D1653950702", "https://twitter.com/intent/tweet?url=https://consumer.healthday.com/infectious-disease-information-21/virus-health-news-697/dos-vacunas-experimentales-contra-el-eacute-bola-muestran-potencial-708423.html&text=Dos%20vacunas%20experimentales%20contra%20el%20%C3%A9bola%20muestran%20potencial&", "https://consumer.healthday.com/infectious-disease-information-21/virus-health-news-697/dos-vacunas-experimentales-contra-el-eacute-bola-muestran-potencial-708423.html", "https://consumer.healthday.com/rsv-2665720322.html", "https://consumer.healthday.com/many-americans-frustrated-in-search-for-low-cost-covid-boosters-2665711360.html", "https://consumer.healthday.com/obesity-2665715704.html", "https://consumer.healthday.com/kraft-cheese-recall-2665715659.html", "https://consumer.healthday.com/vaping-and-asthma-2665629116.html", "https://consumer.healthday.com/diabetes-drugs-2665700605.html", "https://consumer.healthday.com/esophageal-cancer-2665694301.html", "https://consumer.healthday.com/covid-symptoms-2665582081.html", "https://consumer.healthday.com/covid-test-2665708742.html", "https://consumer.healthday.com/syphilis-2665630313.html", "/", "https://www.facebook.com/HealthDayNews", "https://twitter.com/healthdayeditor", "https://www.linkedin.com/company/healthday-news_2/", "https://www.youtube.com/channel/UCSGE_xgCHJSxb7Ey4HeR-lw", "/about-us/", "/products/", "/custom-content/", "/how-its-sold/", "/our-results/", "/how-its-delivered", "/contact-us/", "/blog/", "/privacy", "/healthday-faqs", "/legal", "/", null, "/"]}